Evidence map›Paper›PMID 32410690›Full record

ArticleCritical care (London, England)2020

Age and sex differences in soluble ACE2 may give insights for COVID-19.

Per Swärd, Andreas Edsfeldt, Anton Reepalu, Lars Jehpsson, Björn E Rosengren, Magnus K Karlsson

Abstract readLetter
In one paragraph

Article in Critical care (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19.International journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Circulating angiotensin converting enzyme 2 and COVID-19.World journal of clinical cases · 2022
    Review
  19. Article
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Per SwärdClinical and Molecular Osteoporosis Research Unit, Departments of Orthopedics and Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden. per.sward@skane.se.ORCID http://orcid.org/0000-0003-1857-7089
Andreas EdsfeldtDepartment of Cardiovascular Research-Translational Studies and Cardiology, Skåne University Hospital, Lund University, Malmö, Sweden.
Anton ReepaluDepartment of Translational Medicine and Clinical Infection Medicine, Skåne University Hospital, Lund University, Malmö, Sweden.
Lars JehpssonClinical and Molecular Osteoporosis Research Unit, Departments of Orthopedics and Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden.
Björn E RosengrenClinical and Molecular Osteoporosis Research Unit, Departments of Orthopedics and Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden.
Magnus K KarlssonClinical and Molecular Osteoporosis Research Unit, Departments of Orthopedics and Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAge FactorsAngiotensin-Converting Enzyme 2ChildCoronavirus InfectionsCOVID-19FemaleHumansMalePandemicsPeptidyl-Dipeptidase APneumonia, ViralSex FactorsSolubilityYoung AdultACE2 protein, humanAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase A

Identifiers

PMID32410690
PMCPMC7224163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.